Galecto

$5.97
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-0.50%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

You can buy or sell Galecto and other stocks, options, and ETFs commission-free!

About GLTO

Galecto, Inc. operates as a clinical-stage biotechnology company developing therapeutics which are designed to target the biological processes to treat fibrotic and related diseases including cancer. Its product portfolio includes GB0139, GB1211, GB2064, and GB1211.

CEO
Hans Thalsgård Schambye
Employees
28
Headquarters
Copenhagen, Capital Region
Founded
2011
Market Cap
142.89M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
63.48K
High Today
$6.09
Low Today
$5.90
Open Price
$5.95
Volume
20.82K
52 Week High
$17.99
52 Week Low
$5.77

GLTO Earnings

-$55.25
-$36.83
-$18.42
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 13, Pre-Market

You May Also Like

EVH
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure